BBCMF (Lir Life Sciences) Moat Score: 2/10 (As of Jun. 25, 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Moat Score?

Lir Life Sciences BBCMF -80.00% 15 Moat Score is 2 as of Jun. 25, 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100. Among 1,405 Biotechnology companies, Lir Life Sciences ranks better than 58.15% on this metric.

Lir Life Sciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Lir Life Sciences has No Moat: Lir Life Sciences Corp operates in a competitive biotech sector with minimal intellectual property and lacks significant market share or cost advantages, resulting in a very weak moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Lir Life Sciences might have No Moat - Very weak/transient advantages.

Lir Life Sciences  (OTCPK:BBCMF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Lir Life Sciences Moat Score Related Terms

BBCMF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Lir Life Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lir Life Sciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lir Life Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Lir Life Sciences's Moat Score falls into.


BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Lir Life Sciences (BBCMF) has a Moat Score of 2 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Lir Life Sciences ranks #588 out of 1405 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Lir Life Sciences' Moat Score too high?
Lir Life Sciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Lir Life Sciences' value of 2 is 0% at this industry median. Based on the distribution chart, Lir Life Sciences ranks #588 out of 1405 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lir Life Sciences ranks #588 out of 1405 companies for Moat Score. This puts Lir Life Sciences in the upper half of its industry. The industry median Moat Score is 2.00. Lir Life Sciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,405 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lir Life Sciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lir Life Sciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Moat Score is 2 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price